Arrowstreet Capital Limited Partnership Has $362,000 Stock Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Arrowstreet Capital Limited Partnership grew its holdings in Nu Skin Enterprises, Inc. (NYSE:NUS) by 92.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 52,480 shares of the company’s stock after purchasing an additional 25,243 shares during the period. Arrowstreet Capital Limited Partnership owned approximately 0.11% of Nu Skin Enterprises worth $362,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of NUS. US Bancorp DE increased its position in Nu Skin Enterprises by 424.2% during the 4th quarter. US Bancorp DE now owns 7,460 shares of the company’s stock worth $51,000 after purchasing an additional 6,037 shares in the last quarter. Signaturefd LLC grew its stake in shares of Nu Skin Enterprises by 536.8% during the fourth quarter. Signaturefd LLC now owns 8,087 shares of the company’s stock worth $56,000 after buying an additional 6,817 shares during the last quarter. PNC Financial Services Group Inc. increased its holdings in shares of Nu Skin Enterprises by 2,412.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company’s stock worth $57,000 after buying an additional 7,888 shares in the last quarter. Virtu Financial LLC bought a new position in shares of Nu Skin Enterprises in the 3rd quarter valued at $93,000. Finally, Amundi acquired a new stake in shares of Nu Skin Enterprises during the 4th quarter valued at $104,000. Institutional investors and hedge funds own 82.84% of the company’s stock.

Nu Skin Enterprises Price Performance

Shares of NYSE:NUS opened at $6.23 on Monday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. Nu Skin Enterprises, Inc. has a 52 week low of $5.75 and a 52 week high of $14.00. The firm has a market cap of $309.53 million, a PE ratio of -2.11 and a beta of 1.10. The firm’s fifty day moving average is $7.28 and its 200-day moving average is $7.02.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.24 by $0.14. The firm had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. Sell-side analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th were issued a dividend of $0.06 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 annualized dividend and a yield of 3.86%. Nu Skin Enterprises’s payout ratio is -8.14%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on NUS shares. StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Tuesday, April 8th. DA Davidson reduced their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a report on Friday, December 20th.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.